Can sexology consultations restore intimacy after throat cancer surgery?
NCT ID NCT06517355
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a series of sexology consultations can help people who had their voice box removed due to throat cancer, along with their partners, feel better about their intimate lives. The program involves individual talks with a trained sexology nurse and questionnaires about quality of life and sexual function. The goal is to see if patients find this support acceptable and satisfying.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- onco-sexology consultations
- What this could lead to
- If successful, this program could become a standard support option to help laryngectomy patients and their partners regain intimacy and sexual satisfaction after cancer treatment.
- What could go wrong
- This is a small, early pilot study with only 45 participants, so results may not apply to everyone. The program relies on patient willingness to attend multiple sessions, which may limit its real-world use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 45 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2024
- Expected to finish
-
Mar 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with cancer (ORL) treated by laryngectomy.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: For patients: 1. Patient to be treated for ORL cancer by total (pharyngo)laryngectomy 2. Patient WHO 0-1-2 3. Age greater than or equal to 18 years 4. Patient who has not objected to participation in the study. For partners (if applicable) : 1. Age greater than or equal to 18 years 2. Subject who has not objected to participation in the study. Exclusion Criteria: For patients: 1. Patient with another co-existing malignant disease at the time of inclusion. 2. Any psychological, familial, geographical or sociological condition that does not allow for compliance with the medical follow-up and/or procedures foreseen in the study protocol. 3. Patients deprived of their liberty or under legal protection (guardianship and tutorship, safeguard of justice). For partners (if applicable): 1\. Patients deprived of their liberty or under legal protection (guardianship and tutorship, safeguard of justice).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Orl cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
IUCT-O
RECRUITINGToulouse, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.